Combined Immunotherapies in Metastatic ER+ Breast Cancer
Combined Immunotherapies in Metastatic ER+ Breast Cancer
Recruiting · NCT04563507 · Registry updated 2025-12-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combined Immunotherapies in Metastatic ER+ Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-12-15 | NCT04563507 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Weill Medical College of Cornell University | 276 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brooklyn Methodist Hospital - NewYork Presbyterian | New York | United States | 8 |
| New York Presbyterian Hospital - Queens | New York | United States | 7 |
| Weill Cornell Medicine | New York | United States | 122 |